Theme editorial| Volume 18, ISSUE 4, P575-583, December 1997

Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective

      This paper is only available as a PDF. To read, Please Download here.


      For almost two decades, two types of platelet products have been available: pooled random donor platelets (RDP), manufactured from whole blood donations and single donor platelets (SDP), manufactured on apheresis devices. During this period, two trends have occurred—an overall increase in demand for platelets and a preference for the use of SDP.
      The reasons for the disproportionate increase in the use of SDP relates in all likelihood to supply logistics, perceptions of quality, lack of price sensitivity on the part of prescribing physicians, and minimizing donor exposures in an era of uncertainty and litigation surrounding the allogeneic blood supply.
      In the cost-conscious 1990s, it is essential to reappraise the situation and perform a critical analysis of the relative value of these products. Such an analysis leads to an inescapable conclusion that preferential use of RDP is the more logical strategy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • NIH Consensus Conference
        Platelet transfusion therapy.
        Transfus Med Rev. 1987; 3: 195-200
        • Heyman MR
        • Shiffer CA
        Platelet transtusion therapy for the cancer patient.
        Semin Oncol. 1990; 17: 198-209
        • Surgenor DM
        • Wallace EL
        • Hao SH
        • Chapman RH
        Collection and transfusion of blood in the United States, 1982–1988.
        N Engl J Med. 1990; 322: 1646-1651
        • Wallace EL
        • Churchill WH
        • Surgenor DM
        Collection and transfusion of blood and blood components in the United States, 1992.
        Transfusion. 1995; 35: 802-812
        • Devine P
        • Goldstein R
        • Linden JV
        • Postoway N
        • Hoffstadter LK
        • Hines DM
        Data on apheresis, blood collection and transfusion related activities: statistical analyses of the American Association of Blood Banks institutional membership questionnaires.
        Transfusion. 1996; 36: 375-381
        • Kuriyan M
        • Opalka A
        Leukodepleted platelet apheresis production with a modified COBE Spectra collection protocol.
        J Clin Apher. 1995; 10: 85-86
        • Drew MJ
        • Hodges J
        Research and development in the blood bank: efforts of a hospital donor center to improve efficiency in line leukocyte reduction filters for automated platelet pheresis.
        J Clin Apher. 1995; 10: 76-80
        • Sweeney JD
        • Holme S
        • Heaton A
        Quality of platelet concentrates.
        Immun Invest. 1995; 24: 353-370
        • Murphy S
        • Rebulla P
        • Bertonini F
        In vitro assessment of the quality of stored platelet concentrates.
        Trans Med Rev. 1994; 8: 29-36
        • Samaza K
        Reports of 335 transfusion associated deaths: 1976–1985.
        Transfusion. 1990; 30: 583-590
        • Morrow IF
        • Braine HG
        • Kickler TS
        • Ness PM
        • Dick JD
        • Fuller AK
        Septic reactions to platelet transfusions.
        J Am Med Assoc. 1991; 266: 555-558
        • Chiu EKW
        • Yuen KY
        • Lie AKW
        A prospective study of symptomatic bacteremia following platelet transfusion and its management.
        Transfusion. 1994; 34: 950-954
        • Schreiber GB
        • Busch MP
        • Kleinman SH
        • Korelitz JJ
        • REDS group
        The risk of transfusion transmitted viral infections.
        N Engl J Med. 1996; 334: 1685-1690
        • Anderson NA
        • Gray S
        • Copplestone JA
        A prospective randomized study of three types of plate concentrates in patients with hematological malignance corrected platelet count increments and frequency of non hemolytic febrile transfusion reactions.
        Trans Med. 1996; 6: 33-39
        • Heddle NM
        • Klama LN
        • Griffith L
        A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions.
        Transfusion. 1993; 33: 794-797
        • Goodnough LT
        • Rikkell 4th, J
        • Lazarus H
        Prevalence of platelet transfusion reactions before and after implementation of leukocyte-depleted platelet concentrates by filtration.
        Vox Sanguinis. 1993; 65: 103-107
        • Sweeney JD
        • Holme S
        • Heaton WAL
        • Stromberg RR
        In vitro and in vivo effects of pre-storage filtration of apheresis platelets.
        Transfusion. 1995; 35: 125-130
        • Sweeney JD
        • Holme S
        • Heaton WAL
        • Nelson E
        Leukodepleted platelet concentrates prepared by in filtration of platelet rich plasma.
        Transfusion. 1995; 35: 131-136
        • O'Connell BA
        • Shiffer CA
        Donor selection of alloimmunized patients by platelet crossmatching of random donor platelet concentrates.
        Transfusion. 1990; 30: 314-317
        • Julius CJ
        • Sytsma SR
        Comparison of demographics and motivations of highly committed whole blood and platelet donors.
        J Clin Apher. 1993; 8: 82-88
        • Bloom BS
        • Hillman AL
        • Fendrick AM
        • Schwartz JS
        A reappraisal of Hepatitis B virus vaccination strategies using cost-effective analysis.
        Ann Intern Med. 1993; 118: 298-306
        • Wong DK
        • Cheung AM
        • O'Rourke K
        • Naylor CD
        • Detsky AS
        • Heathcote J
        Effect of interferon treatment in patients with Hepatitis B antigen positive chronic Hepatitis B.
        Ann Intern Med. 1993; 119: 110-115
        • Koretz RL
        • Abbey H
        • Coleman E
        • Gitnick G
        Non A, non B post transfusion Hepatitis.
        Ann Intern Me. 1993; 119: 110-115
        • Seeff LB
        • Buskell-Bales Z
        • Wright EC
        Long term mortality after transfusion associated non A non B Hepatitis.
        N Engl J Med. 1992; 327: 1906-1911
        • Lopez-Plaza I
        • Weissfeld J
        • Truilzi DJ
        Cost effectiveness of single donor (SD) versus pooled platelet (PD) for avoiding donor exposures in primary coronary arteries bypass grafting (CABG).
        Transfusion. 1996; 36: 47S
        • Bowden RA
        • Slichter SJ
        • Seyers M
        A comparison of filtered leukocytereduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion associated CM infection after bone marrow transplant.
        Blood. 1995; 86: 3598-3603
        • Sowemimo-Coker SO
        • Brandwein H
        • Wenz B
        Analysis of leukocyte subsets in leukoreduced products.
        in: Proc 20th Annual Meeting, MAABB, Towson, MDApril, 1997